If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Director/PDMR Shareholding - Correction

25 Jan 2024 14:30

RNS Number : 9539A
Indivior PLC
25 January 2024

INDIVIOR PLC (THE 'COMPANY') - DIRECTOR/PDMR SHAREHOLDINGS - CORRECTION

The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on March 8, 2023 at 09:42 under RNS number: 3033S

In relation to the shares acquired by Mark Stejbach on March 6, 2023, the number of shares purchased was incorrectly stated due to administrative error and has been corrected from 1,400 to 1,300.

As at the date of this announcement, Mark Stejbach has an interest in 12,584 shares in the Company.

All other details remain unchanged.

The full amended text is shown below.

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that it received notification on March 7, 2023 that Mark Stejbach, aNon-Executive Director of the Company, acquired 1,300 shares at an average price of £15.0229 per share on March 6, 2023.

Following this transaction, Mark Stejbach has an interest in 9,584 shares in the Company.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Stejbach

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Amendment

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Indivior PLC

b)

LEI

213800V3NCQTY7IED471

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of US$0.50

ISIN: GB00BN4HT335

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP £15.0229

1,300

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

March 6, 2023

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUVVORSBUAUAR
Date   Source Headline
28th Nov 20227:00 amRNSTransaction in Own Shares
25th Nov 20227:00 amRNSTransaction in Own Shares
24th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20224:25 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20222:36 pmRNSHolding(s) in Company
22nd Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 202210:00 amRNSDirector Declaration
15th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20227:00 amRNSIndivior To Acquire Opiant Pharmaceuticals
14th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20224:46 pmRNSBlock listing Interim Review
9th Nov 20228:30 amRNSIndivior to Host Capital Markets Day December 7
9th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 202210:48 amRNSHolding(s) in Company
8th Nov 20227:00 amRNSTransaction in Own Shares
7th Nov 20227:00 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20229:28 amRNSTotal Voting Rights
1st Nov 20229:08 amRNSIndivior to Participate in Conference
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20228:07 amRNS3rd Quarter Results
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:26 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSTransaction in Own Shares
25th Oct 202212:24 pmRNSHolding(s) in Company
25th Oct 202212:17 pmRNSHolding(s) in Company
25th Oct 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20224:04 pmRNSHolding(s) in Company
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:27 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 202211:41 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSIndivior updates Board Succession Plans
13th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.